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1. Introduction 2. Materials and methods 
It is well known that the extracellular mammalian 
aspartic proteinases pepsin and chymosin are synthe- 
sised in the form of their zymogens which can then 
be converted by limited proteolysis to the physiologi- 
cally active forms. In this process amino-terminal 
activation segment peptides are cleaved off from the 
zymogen molecule [l-7]. Some of the peptides 
released during pepsinogen activation can inhibit 
active enzymes to varying extents [ l,S-71. It has 
been shown that the conversion of pepsinogen to 
pepsin at pH < 3 occurs predominantly as a first- 
order intramolecular activation process [8-lo]. 
Sephadex G-l 00, Sepharose 4B, AH-Sepharose 4B 
and protein markers were obtained from Pharmacia 
Fine Chemicals AB. Pepstatin was purchased from the 
Peptide Institute, Japan. Cyanogen bromide was from 
Sigma Chemicals. All other chemicals used were of 
reagent grade. 
2.1. Isolation of precursor 
In contrast, there are only a few reports concern- 
ing the existence of lysosomal enzymes in the form of 
precursors [ 1 l-l 51. Among them the main lysosomal 
aspartic proteinase, cathepsin D, was detected in a 
higher M, precursor form during biosynthesis in 
microsomal vesicles [ 12,131 and cultured human 
fibroblasts [ 14,151. Some of our studies also indi- 
cated the possibility of the existence of cathepsin D 
zymogen [16,17]. 
This work reports the isolation of a higher M, 
inactive protein which, after brief acid treatment 
between pH 2.5-3.5, can release cathepsin D and 
activation peptides. Three of the peptides released 
show inhibitory activity towards active cathepsin D. 
We present evidence for the existence of a cathepsin D 
zymogen, and suggest hat it can be activated by a 
similar mechanism to that involved in the activation 
of pepsinogen. 
Cathepsin D precursor was isolated from bovine 
spleen by a purification procedure [ 16,181, with the 
modification that ammonium sulphate and acetone 
precipitation steps were omitted. The supernatant 
(pH 6.3) was directly concentrated by ultrafiltration 
(Amicon HlPlO Diaflo membranes) to 1/3rd of the 
initial volume, adjusted to pH 5.0 by the addition of 
1/4th the volume of 0.4 M Na-acetate/4 M NaCl 
(pH 5.0) buffer and 0.1 M acetic acid and then cen- 
trifuged at 5000 X g for 10 min in a Sorvall refriger- 
ated centrifuge, GSA rotor at 3’C. The clear protein 
solution containing 30-50 mg protein/ml was imme- 
diately applied to pepstatin-Sepharose resin and fur- 
ther chromatographed by gel chromatography on 
Sephadex G-l 00 as in [ 16,181. Proteolytically active 
fractions eluted in the first protein peak were pooled, 
concentrated by ultrafiltration and used as purified 
cathepsin D precursor. 
2.2. Activation of precursor 
Abbreviations: SDS, sodium dodecyl sulphate; PAGE, poly- 
acrylamide gel electrophoresis; MI, relative molecular mass 
This paper is dedicated to Helmut Holzer, Professor of Bio- 
chemistry, University of Freiburg, FRG, on the occasion of 
his 60th birthday 
The 5 ml precursor solution (7.2 mg protein) was 
acidified with 1 M acetic acid to pH 3.5 and immedi- 
ately applied to the immobilized cathepsin D column 
(1.3 X 4.0 cm). Cathepsin D was covalently bound to 
Sepharose 4B by the cyanogen bromide procedure 
[ 191. After loading the sample on to the column, the 
resin was washed with 0.1 M Na-acetate buffer/O.1 M 
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NaCl (pH 3.5) until the released cathepsin D and 
other non-bound material was eluted completely. 
Further elution was carried out by the addition of the 
same buffer at pH 5.0. Later, solutions of 0.1 M 
NaCl/O.l M Tris-HCl (pH 6.8) and 0.5 M NaCl/O.l M 
Tris-HCl (pH 8.6) were applied to the column. The 
whole of the activation process was done in the cold 
room at 3°C. 
2.3. Inhibition studies 
The inhibition of cathepsin D with released inhibi- 
tory peptides and pepstatin was determined by 
cathepsin D assay. A known amount of cathepsin D 
(0.4 X 10e6 PM) was titrated with increasing amounts 
of inhibitory peptide and the residual enzyme activity 
was plotted against mol inhibitor/m01 enzyme. For 
the determination of mol cathepsin D, a specific 
absorbancy Ai& of 10.5 was assumed [20]. 
2.4. Polyacrylamide gel electrophoresis 
PAGE was done as in [21] using 7.5% acrylamide 
with 2.5% stacking gels (0.5 X 5.0 cm) in a Tris-gly- 
tine buffer (pH 8.9). SDS-PAGE was performed by 
the method in [22]. Gels (0.5 X 9.5 cm) containing 
10% acrylamide were loaded with protein samples 
dissolved in 1% SDS and 0.1% /?-mercaptoethanol. 
After electrophoresis, gels were stained for protein 
with Coomassie brilliant blue R-250. The Mr stan- 
dards were bovine serum albumin (68 000) ovalbumin 
(45 000) carbonic anhydrase (30 000) soybean tryp- 
sin inhibitor (20 100) and cu-lactalbumin (14 400). 
2.5. Other analytical methods 
Cathepsin D activity was determined as in [ 161. 
Protein concentration was determined as in [23]. 
Peptides were identified by the ninhydrin method 
[24]. The amino acid analyses were performed with a 
Beckman model 1 18 CL amino acid analyzer using 
4 N methanesulphonic acid containing 0.2% 3-(2- 
aminoethyl)indole (Pierce) as in [25].Mr-Value was 
determined by gel filtration on Sephadex G-l 00 by 
the method in [26] and SDS-PAGE as in [22]. 
3. Results 
Purified cathepsin D precursor was acidified to dif- 
ferent pH-values and checked for cathepsin D activity 
(fig.1). It is evident that the maximal release of pro- 
teolytic activity occurred between pH 2.5-3.5. 
300 
Fig.1 The pH dependence of the release of cathepsin D from 
its precursor. To 0.05 ml precursor (1.44 mg protein/ml) 
0.350 ml buffer was added. From pH 2.3-3.0, 0.1 M citrate 
buffer and from pH 3.0-5 S, 0.1 M acetate buffer was used. 
After 2 min preincubation at room temperature the samples 
were assayed for enzyme activity. 
Because of the instability of cathepsin D in this acid 
region, it is necessary after the activation process to 
apply the sample to the immobilized cathepsin D col- 
umn immediately. Immobilized cathepsin D was used 
for the separation of inhibitory peptides because of 
its high expected specificity to these released inhibi- 
tory peptides. Fig.2 illustrates the elution profile 
which was obtained. The cathepsin D activity was 
eluted in the first peak. It should be added that the 
appearance of the small proteolytically active peak 
was always detected through several experiments. The 
inhibitory peptides were bound to the column under 
these conditions and eluted under changed elution 
conditions. Three peptides were eluted and fractions 
were assayed for inhibitory activity. From the elution 
profile, the successful separation of three inhibitory 
peptides designated A, B and C, respectively, is evi- 
dent. Whereas the first two peptides show some 
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Fig.2. Affinity chromatography of activated cathepsinogen D on immobilized cathepsin D-Sepharose 4B resin. Arrows a, b and c 
indicate the elution buffers changes to pH 5.0, pH 8.6 in 0.1 M NaCl and pH 8.6 in 0.5 M NaCl, respectively. Fractions of 2.5 ml 
were collected and 0.2 ml was assayed for enzyme activity, ninhydrin reaction. Peptide inhibition: 0.2 ml fraction was added to 
0.2 ml cathepsin D sample, preincubated at room temperature for 10 min and assayed for the remaining enzyme activity. Spec- 
trum of: (-) protein A,,,; (---) cathepsin D activity, A,,,; (-.-.) peptide (ninhydrin reaction A ). ( 570 9 ‘.. ) inhibitory activity, 
A 750’ 
absorbance at 280 nm, peptide C shows practically no 
absorbance in this region, indicating a very low con- 68000 
tent of aromatic acid residues or their absence. In 
fig.3 the polypeptide composition of purified cathep- 115 000 
sin D precursor on SDS-PAGE, besides a protein 
band in the upper part of the gel (under investiga- 
tion) shows the presence of a polypeptide chain of 
Mr - 30 000 and a faint band M, - l& 000 (gel C), 
30000 
indicating the presence of cathepsin D polypeptide 
chains (gel B). PAGE of activated cathepsin D gives 
practically a single band which corresponds to one of 
the multiple forms of cathepsin D (gel D). Addition- 20 100 
ally, M, of - 45 000 for activated cathepsin D was 
14400 
Fig.3. Polyacrylamide gel electrophoresis. In the presence 
of SDS and p-mercaptoethanol: (A) marker proteins; (B) two 
polypeptide chains of cathepsin D (Mr 45 000 and -29 OOO- 
30 000); (C) polypeptide composition of cathepsinogen D 
before activation;(D) at pH 8.9, the released cathepsin D. 
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Fig.4. Interaction of cathepsin D with the released inhibitory 
peptide from cathepsinogen D. Increasing amounts of a solu- 
tion, containing inhibitory peptide B (starting from 0.025 ml) 
were added to known amount of cathepsin D (0.4 X low6 PM) 
and the remaining enzyme activity was measured. 
obtained bv gel chromatography on Sephadex G-l 00 
(not shown). The pentapeptide pepstatin, the most 
powerful inhibitor of aspartic proteinases, completely 
inhibits cathepsin D activity at 1 O-’ M (mol/mol). 
Increasing amounts of peptide B were added to the 
known amount of cathepsin D in the assay and the 
percentage inhibition was calculated at each concen- 
tration of inhibitor. The result presented in fig.4 
shows that -7 mol inhibitory peptide B is needed for 
complete inhibition of 1 mol cathepsin D. The con- 
centration of the inhibitory peptide was calculated 
from the amount of the released cathepsin D from its 
zymogen, assuming that 1 mol peptide is liberated/ 
1 molecule cathepsin D. 
The amino acid composition of the activation pep- 
tide B is presented and compared with that found in 
pig and bovine pepsinogen (table 1). There is evi- 
dently a similarity between cathepsinogen D activa- 
tion peptide B and the activation segment obtained 
from pig pepsinogen and bovine pepsinogen residues 
18-45. 
Table 1 
Amino acid composition (mol residue/mol) of bovine cathepsinogen D inhibitory 
peptide B, pig and bovine pepsinogen activation peptides 
Amino Bovine cathep- Pig pepsinogenb Bovine pepsinogenC 
acid sinogen Da 
found Activation Residues Residues Residues 
peptide, found l-44 l-45 18845 
LYS 2.31 (2) 4.60 9 8 
His 1.00 (1) 1.34 2 1 
Arg 1.37 (l-2) 1.14 2 3 
Asp 2.98 (3) 4.00 4 3 
Thr 1.82 (2) 1.28 1 2 
Ser 1.31 (l-2) 2.16 2 3 
Glu 2.52 (3) 2.52 2 4 
Pro 1.38 (1) 2.26 3 1 
GIY 4.14 (4) 2.20 1 2 
Ala 2.23 (2) 2.88 4 2 
Val 1.29 (1) 2.20 3 3 
Met 0.68 (1) 0.00 0 1 
Be 1.46 (l-2) 1.32 1 3 
Leu 2.13 (2) 4.85 I 6 
Tyr 1.17 (1) 0.95 1 2 
Phe 0.86 (1) 1.36 2 1 
3 
0 
2 
2 
0 
1 
2 
3 
2 
1 
Total 27-30 44 45 
a Time-course hydrolysis: 24 h and 48 h; b See [3,5]; c See [4] 
28 
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4. Discussion 
The rapid purification procedure which we have 
developed for cathepsin D and which includes affinity 
chromatography on pepstatin-agarose [ 181 enabled 
us to isolate both cathepsin D and an inactive protein 
which represents a cathepsin D zymogen, cathepsin- 
ogen D. This zymogen binds to immobilized pepstatin 
at pH 5 .O and is recovered by elution at higher pH in 
a similar fashion to that reported for porcine pepsin- 
ogen [lo] and cathepsin D isozymes from porcine 
spleen [27]. While activation of the zymogen has 
been shown to take place rapidly at pH 3 S, this pro- 
cess is minimized by exposing it to these conditions 
for a brief time only and at 3°C. It is still possible, 
however, that a large proportion of the precursor is 
converted to active enzyme at this point in the isola- 
tion procedure and that the yield of the precursor 
obtained here does not represent the total amount in 
the tissue. Many other purification procedures for 
cathepsin D include an autolysis step (review [28]) 
and this may be one of the reasons why the zymogen 
had not been isolated. The activation of cathepsin- 
ogen D is pH-dependent, like that for pepsinogen 
[4,5]. However, unlike pepsin, cathepsin D is unstable 
at pH < 4.0 [28] so that the enzyme must be exposed 
to low pH for as short a time as possible. After activa- 
tion, three peptides were bound to immobilized 
cathepsin D while active enzyme and other inactive 
material including possible non-inhibiting peptides 
released during the activation process, passed through 
the column. The bound peptides were eluted sepa- 
rately under different elution conditions indicating 
differences in their ability to bind the enzyme. These 
peptides inhibit cathepsin D activity and this phenom- 
enon may account for the earlier report that cathep- 
sin D activity was increased after gel filtration [ 161. 
While electrophoresis indicates the presence of cathep- 
sin D in the inactive protein, the M, of the activated 
enzyme and its inhibition by pepstatin proved the 
release of cathepsin D from the inactive form. It was 
recently reported that a cathepsin D precursor of 
M, 53 000 synthesized in human fibroblasts is inac- 
tive and can be processed through intermediate steps 
to M, 3 1 000 and 14 000 polypeptide chains [ 141. 
The amino acid composition of the released pep- 
tide B and its N-terminal amino acid, Ile (preliminary 
result), suggests a close similarity with the pepsino- 
gen activation process. There is a high probability 
that this peptide of -27 amino acid residues, with 
4 - 3000, corresponds to the activation peptide 
which is released during cleavage of the Leu 16-Ile 17 
bond in pig and Leu 17%Ile 18 in cow pepsinogen, as 
summarized in [4,5]. The lower yields of some amino 
acids found in the pig pepsinogen activation segment, 
compared to intact residues of l-44 of pig pepsino- 
gen (table 1) may be due to their having been released 
as small peptides [3]. It should be added at this point 
that it has been impossible to isolate the intact acti- 
vation segment of -45 amino acid residues from pep- 
sinogen molecule during the activation process. There- 
fore, we can assume that also in our experiments we 
were not able to isolate the intact cathepsinogen D 
activation peptide of -45 residues with M, - 5000. 
In [ 131, an activation peptide of 44 amino acids was 
removed from procathepsin D soon after synthesis in 
vivo, yielding enzymatically active cathepsin D in a 
single chain of MI 44 000 which undergoes further 
cleavage into an enzymatically active two-chain form. 
From the measurements of the inhibition of 
cathepsin D with the released peptide we can assume 
that the dissociation constant of the complex is mod- 
erate. Several inhibitory peptides were released during 
porcine pepsinogen activation with different apparent 
dissociation constants for the peptide-pepsin inter- 
action [6]. These results suggest herefore, that the 
activation of cathepsinogen D is similar to pepsinogen 
activation, which occurs predominantly as an intra- 
molecular process at acid pH releasing activation pep- 
tides. 
Ten years ago the existence of a precursor of 
cathepsin D from chicken liver was suggested [29]. 
Later the isolation of a high M, cathepsin D isozyme 
ofM, - 100 000 with low specific activity was 
reported [27] and it was suggested that this is the 
precursor form which can be converted to a two- 
chain enzyme. Our results show that the activation of 
cathepsinogen D occurs through a different process. 
From the M, of cathepsin D and of the activation pep- 
tide we can conclude that cathepsin D precursor has 
an M, of -50 000 and can be converted by intramo- 
lecular activation to the active enzyme and activation 
segment-peptide( Further studies are in progress. 
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